Compare SPH & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPH | ALVO |
|---|---|---|
| Founded | 1945 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | 1460 |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.1B |
| IPO Year | 1996 | N/A |
| Metric | SPH | ALVO |
|---|---|---|
| Price | $19.53 | $3.57 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 78.8K | ★ 541.3K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 6.62% | N/A |
| EPS Growth | ★ 42.11 | N/A |
| EPS | ★ 0.69 | N/A |
| Revenue | ★ $1,432,518,000.00 | N/A |
| Revenue This Year | $2.06 | $12.28 |
| Revenue Next Year | $1.64 | $21.29 |
| P/E Ratio | $28.46 | ★ $18.20 |
| Revenue Growth | ★ 7.94 | N/A |
| 52 Week Low | $17.30 | $3.03 |
| 52 Week High | $21.21 | $11.85 |
| Indicator | SPH | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 39.23 | 47.08 |
| Support Level | $19.15 | $3.03 |
| Resistance Level | $19.64 | $3.93 |
| Average True Range (ATR) | 0.48 | 0.21 |
| MACD | -0.07 | 0.06 |
| Stochastic Oscillator | 32.28 | 57.99 |
Suburban Propane Partners LP distributes propane, renewable propane, renewable natural gas (RNG), fuel oil, refined fuels, and markets natural gas and electricity in deregulated markets. It produces and invests in low-carbon fuel alternatives. The company installs and services home comfort heating and ventilation equipment and distributes fuel oil, kerosene, diesel, and gasoline to about 25,000 residential and commercial customers mainly in the U.S. northeast. It operates three segments: Propane, Fuel Oil and Refined Fuels, and Natural Gas and Electricity, with the Propane segment generating the majority of revenue. Propane, a by-product of natural gas processing and petroleum refining, is a clean-burning energy source known for transportability and ease of use.
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.